425 related articles for article (PubMed ID: 36377292)
1. The Seroprevalence of SARS-CoV-2 in Children During Early COVID-19 Pandemic in Korea: A Nationwide, Population-Based Study.
Lee J; Choe YJ; Minn D; Kim JH
J Korean Med Sci; 2022 Nov; 37(44):e314. PubMed ID: 36377292
[TBL] [Abstract][Full Text] [Related]
2. Low Prevalence of SARS-CoV-2 Antibodies in Canine and Feline Serum Samples Collected during the COVID-19 Pandemic in Hong Kong and Korea.
Go YY; Carrai M; Choi YR; Brackman CJ; Tam KWS; Law PYT; Woodhouse F; Gray J; Kim JH; Park J; Jeon CW; Jang H; Magouras I; Decaro N; Cheng SMS; Peiris M; Beatty JA; Barrs VR
Viruses; 2023 Feb; 15(2):. PubMed ID: 36851796
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of antibodies against SARS-CoV-2 in the Norwegian population, August 2021.
Tunheim G; Rø GØI; Chopra A; Aase A; Kran AB; Vaage JT; Lund-Johansen F; Hungnes O
Influenza Other Respir Viruses; 2022 Nov; 16(6):1004-1013. PubMed ID: 35770841
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of SARS-CoV-2 antibodies in the community based on participants in the 2020 Korea National Health and Nutrition Examination Survey.
Kim AR; Minn D; Kim SH; Do HN; Kim B; Choi YS; Kim DH; Oh EJ; Oh K; Kwon D; Kwon JW; Kim SS; Lee JW
Epidemiol Health; 2022; 44():e2022028. PubMed ID: 35209706
[TBL] [Abstract][Full Text] [Related]
5. National population prevalence of antibodies to SARS-CoV-2 in Scotland during the first and second waves of the COVID-19 pandemic.
Palmateer NE; Dickson E; Furrie E; Godber I; Goldberg DJ; Gousias P; Jarvis L; Mathie L; Mavin S; McMenamin J; McNeilly TN; Murcia P; Murray J; Reid G; Robertson C; Templeton K; von Wissmann B; Wallace LA; Waugh C; McAuley A
Public Health; 2021 Sep; 198():102-105. PubMed ID: 34411992
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 seroprevalence among children in Latvia: A cross-sectional study.
Sapronova K; Kaķe R; Pavāre J; Grāvele D; Šēla I; Ērgle E; Isarova D; Grīnberga Z; Zavadska D
Medicine (Baltimore); 2023 Feb; 102(6):e32795. PubMed ID: 36820593
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal change in SARS-CoV-2 seroprevalence in 3-to 16-year-old children: The Augsburg Plus study.
Leone V; Meisinger C; Temizel S; Kling E; Gerstlauer M; Frühwald MC; Burkhardt K
PLoS One; 2022; 17(8):e0272874. PubMed ID: 35951611
[TBL] [Abstract][Full Text] [Related]
8. Realistic Estimation of COVID-19 Infection by Seroprevalence Surveillance of SARS-CoV-2 Antibodies: An Experience From Korea Metropolitan Area From January to May 2022.
Jeong IH; Kim JH; Kwon MJ; Kim J; Huh HJ; Kim B; Lee J; Nam JH; Kang ES
J Korean Med Sci; 2024 Feb; 39(5):e43. PubMed ID: 38317445
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Seroprevalence in Children from Western Romania, March to June 2021.
Olariu TR; Craciun AC; Vlad DC; Dumitrascu V; Pop LL; Horhat F; Lupu MA
Vector Borne Zoonotic Dis; 2022 Apr; 22(4):267-270. PubMed ID: 35384727
[TBL] [Abstract][Full Text] [Related]
10. Nationwide seroprevalence of antibodies to SARS-CoV-2 in asymptomatic population in South Korea: a cross-sectional study.
Nah EH; Cho S; Park H; Hwang I; Cho HI
BMJ Open; 2021 Apr; 11(4):e049837. PubMed ID: 33895722
[TBL] [Abstract][Full Text] [Related]
11. Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia.
Alharbi NK; Alghnam S; Algaissi A; Albalawi H; Alenazi MW; Albargawi AM; Alharbi AG; Alhazmi A; Al Qarni A; Alfarhan A; Zowawi HM; Alhatmi H; Alghamdi J; Alroqi F; Batarfi K; Arabi YM; Hashem AM; Bosaeed M; Aldibasi O
J Infect Public Health; 2021 Jul; 14(7):832-838. PubMed ID: 34118732
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal Randomized Cohort Study of SARS-CoV-2 Antibody Seroprevalence in the St. Petersburg Population.
Smirnov VS; Lyalina LV; Milichkina AM; Khamitova IV; Zueva EV; Ivanov VA; Zaguzov VS; Totolian AA
Viruses; 2022 Apr; 14(5):. PubMed ID: 35632653
[TBL] [Abstract][Full Text] [Related]
13. Korea Seroprevalence Study of Monitoring of SARS-COV-2 Antibody Retention and Transmission (K-SEROSMART): findings from national representative sample.
Han J; Baek HJ; Noh E; Yoon K; Kim JA; Ryu S; Lee KO; Park NY; Jung E; Kim S; Lee H; Hwang YS; Jung J; Lee HJ; Cho SI; Oh S; Kim M; Oh CM; Yu B; Hong YS; Kim K; Jung SJ; Han MA; Lee MS; Lee JJ; Hwangbo Y; Yim HW; Kim YM; Lee J; Lee WY; Park JH; Oh S; Jo HS; Kim H; Kang G; Nam HS; Lee JH; Oh GJ; Shin MH; Ryu S; Hwang TY; Park SW; Kim SK; Seol R; Park KS; Kim SY; Kwon JW; Kim SS; Kim B; Lee JW; Jang EY; Kim AR; Nam J; ; Lee SY; Kim DH
Epidemiol Health; 2023; 45():e2023075. PubMed ID: 37591786
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal Household Assessment of Respiratory Illness in Children and Parents During the COVID-19 Pandemic.
de Hoog MLA; Sluiter-Post JGC; Westerhof I; Fourie E; Heuvelman VD; Boom TT; Euser SM; Badoux P; Reusken C; Bont LJ; Sanders EAM; Jaddoe VWV; Herpers BL; Eggink D; Wildenbeest JG; Duijts L; van Houten MA; Bruijning-Verhagen PCJL
JAMA Netw Open; 2022 Oct; 5(10):e2237522. PubMed ID: 36264578
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of SARS-CoV-2 Antibody in 2,935 Healthcare Workers at 6 Major Hospitals, Daegu, Korea.
Kim YK; Minn D; Song DY; Lee CH; Ryoo NH; Jeon CH; Song KE; Suh JS; Chang SH
J Korean Med Sci; 2021 Nov; 36(43):e294. PubMed ID: 34751011
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 infection- induced seroprevalence among children and associated risk factors during the pre- and omicron-dominant wave, from January 2021 through December 2022, Thailand: A longitudinal study.
Suntronwong N; Vichaiwattana P; Klinfueng S; Puenpa J; Kanokudom S; Assawakosri S; Chansaenroj J; Srimuan D; Thatsanatorn T; Songtaisarana S; Sudhinaraset N; Wanlapakorn N; Poovorawan Y
PLoS One; 2023; 18(4):e0279147. PubMed ID: 37104299
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey.
Hoballah A; El Haidari R; Siblany G; Abdel Sater F; Mansour S; Hassan H; Abou-Abbas L
BMC Infect Dis; 2022 Jan; 22(1):42. PubMed ID: 35012464
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of SARS-CoV-2 infection among children in Children's Hospital Zagreb during the initial and second wave of COVID-19 pandemic in Croatia.
Lenicek Krleza J; Zrinski Topic R; Stevanovic V; Lukic-Grlic A; Tabain I; Misak Z; Roic G; Kaic B; Mayer D; Hruskar Z; Barbic L; Vilibic-Cavlek T
Biochem Med (Zagreb); 2021 Jun; 31(2):020706. PubMed ID: 33927556
[TBL] [Abstract][Full Text] [Related]
19. High SARS-CoV-2 Seroprevalence in Rural Peru, 2021: a Cross-Sectional Population-Based Study.
Moreira-Soto A; Pachamora Diaz JM; González-Auza L; Merino Merino XJ; Schwalb A; Drosten C; Gotuzzo E; Talledo M; Arévalo Ramirez H; Peralta Delgado R; Bocanegra Vargas S; Drexler JF
mSphere; 2021 Dec; 6(6):e0068521. PubMed ID: 34817236
[TBL] [Abstract][Full Text] [Related]
20. Utility of Newborn Dried Blood Spots to Ascertain Seroprevalence of SARS-CoV-2 Antibodies Among Individuals Giving Birth in New York State, November 2019 to November 2021.
Damjanovic A; Styer LM; Nemeth K; Yauney E; Rock JM; Bievenue R; Hoen R; Ehrbar D; Kay DM; Caggana M; Parker MM
JAMA Netw Open; 2022 Aug; 5(8):e2227995. PubMed ID: 35994287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
